Bodhi Tree Biotechnology Inc. (BDTB)

Bodhi Tree Biotechnology Financials Overview

Financials in millions USD. Fiscal year is October - September.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Revenue Revenue Growth	0.03	0.02	0.04
Revenue Growth	-42.55%	-59.52%	-
Gross Profit Gross Profit Growth	0.03	0.02	0.04
Operating Income Operating Income Growth	-0.11	-0.15	-0.07
Net Income Net Income Growth	-0.11	-0.15	-0.07
Earnings Per Share EPS Growth	-0.00	-0.01	-
EPS Growth	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Net Cash (Debt) Net Cash Growth	0.02	0.11	0.26
Net Cash Growth	-84.22%	-57.85%	-
Net Cash Per Share Net Cash Per Share Growth	0.00	0.00	0.02
Cash & Investments Cash & Investments Growth	0.02	0.11	0.26

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Operating Cash Flow Operating Cash Flow Growth	-0.12	-0.15	-0.09
Free Cash Flow Free Cash Flow Growth	-0.12	-0.15	-0.09
Free Cash Flow Growth	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-413.13%	-868.34%	-177.01%
Pretax Margin	-413.12%	-868.33%	-177.01%
Profit Margin	-420.76%	-880.39%	-177.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error